查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1702116

2025 年至 2033 年体内 CRO 市场报告，按类型（囓齿动物、非囓齿动物）、GLP 类型（非 GLP、GLP 毒理学）、适应症（自体免疫/发炎疾病、疼痛管理、肿瘤学、中枢神经系统疾病、糖尿病、肥胖症等）和地区划分

In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2024年全球体内CRO市场规模达53亿美元。展望未来， IMARC Group预计到2033年市场规模将达到98亿美元，2025-2033年期间的成长率（CAGR）为6.76%。全球范围内慢性病的日益普及以及製药公司不断增加的研发支出正在推动市场的成长。

体内合约研究组织（CRO）是根据合约进行广泛生物製药研究的机构。他们透过提供外包服务来支援製药和生物技术公司配製有效的药物、疫苗和医疗设备。与体外CRO相比，体内CRO是在生物体内进行的研究，透过人体临床试验来评估药物的安全性和有效性，而不是对切除的细胞和组织进行检查。它们有助于研究机构管理复杂的医学测试，以最低的成本开发有效的药物，并透过避免招聘、筹款和临床准备造成的延误来优化工作流程。因此，体内 CRO 在疼痛管理、肿瘤学以及治疗中枢神经系统 (CNS) 损伤和其他疾病方面有广泛的应用。目前，它们分为囓齿动物类型和非囓齿动物类型。

体内CRO市场趋势：

各种心血管疾病的发生率不断上升，尤其是在老年人群中，对有效药物和新型肿瘤诊断和治疗疗法的需求不断增长，是推动市场成长的主要因素。此外，合约研究、开发和製造组织 (CRDMO) 对临床规模生产活性药物成分 (API) 的需求不断增长，以及对生物相似药而非单株抗体形式的倾向转变，也是其他促进成长的因素。此外，日益加剧的健康问题促使生技公司与 CRO 合作设计有效的新型疫苗，尤其是在 COVID-19 大流行期间，这有助于市场成长。此外，在临床前活动期间广泛利用体内 CRO 进行毒理学和药物动力学研究正在推动市场成长。除此之外，生物等效性的出现、仿製药的快速增长、专利的不断到期以及个性化药物设计的持续研发活动正在为市场创造积极的前景。

本报告回答的关键问题

  • 2024 年全球体内 CRO 市场规模？ 2025-2033年全球体内CRO市场的预期成长率是多少？
  • 推动全球体内 CRO 市场发展的关键因素有哪些？
  • COVID-19 对全球体内 CRO 市场有何影响？
  • 全球体内 CRO 市场依类型分为哪些类型？
  • 根据 GLP 类型，全球体内 CRO 市场如何分布？
  • 根据适应症，全球体内 CRO 市场如何划分？
  • 全球体内 CRO 市场的关键区域有哪些？
  • 全球体内 CRO 市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球体内CRO市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 囓齿动物
    • 关键部分
      • 大鼠
      • 老鼠
      • 其他的
  • 不囓齿类动物

第七章：市场区隔：依 GLP 类型

  • 非GLP
    • 关键部分
      • 内部
      • 外包
  • GLP毒理学
    • 关键部分
      • 内部
      • 外包

第八章：市场区隔：依指标

  • 自体免疫/发炎状况
    • 关键部分
      • 类风湿关节炎
      • 多发性硬化症
      • 骨关节炎
      • 急躁性肠症候群
      • 其他的
  • 疼痛管理
    • 关键部分
      • 慢性疼痛
      • 急性疼痛
  • 肿瘤学
    • 关键部分
      • 血癌
      • 实体肿瘤
      • 其他的
  • 中枢神经系统疾病
    • 关键部分
      • 癫痫
      • 帕金森氏症
      • 亨廷顿舞蹈症
      • 中风
      • 创伤性脑损伤
      • 肌萎缩侧索硬化症
      • 肌肉再生
      • 其他的
  • 糖尿病
  • 肥胖
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Charles River Laboratories International Inc.
    • Evotec SE
    • ICON plc
    • Iris Pharma (ABIONYX Pharma)
    • Labcorp Drug Development (Laboratory Corporation of America Holdings)
    • North American Science Associates LLC
    • Parexel International Corporation
    • Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.)
    • Pronexus Analytical AB
    • Syneos Health
    • WuXi AppTec
Product Code: SR112025A6267

The global in-vivo CRO market size reached USD 5.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.8 Billion by 2033, exhibiting a growth rate (CAGR) of 6.76% during 2025-2033. The growing prevalence of chronic diseases worldwide and the increasing R&D expenditure by pharmaceutical companies are propelling the market growth.

In-vivo contract research organizations (CROs) are institutions that conduct extensive biopharmaceutical research on a contractual basis. They support pharmaceutical and biotechnology companies in formulating effective drugs, vaccines, and medical devices by providing outsourcing services. As compared to in-vitro CRO, in-vivo CRO deals with the research performed within the living organism and conducts human clinical trials to assess the safety and efficacy of the drugs instead of organizing examinations on removed cells and tissues. They aid research institutions in managing complex medical testing, developing effective medications at minimal costs, and optimizing workflow by avoiding delays caused by hiring, fundraising, and clinical preparations. As a result, in-vivo CRO finds extensive application in pain management, oncology, and treating central nervous system (CNS) injuries and other disorders. Currently, they are bifurcated into rodent- and non-rodent-based types.

In-vivo CRO Market Trends:

The increasing prevalence of various cardiovascular ailments, especially amongst the geriatric population, and the growing need for effective medications and novel oncology-based therapies for diagnosis and treatment are primarily driving the market growth. Additionally, the rising demand for clinical-scale manufacturing of active pharmaceutical ingredients (APIs) by contract research, development, and manufacturing organizations (CRDMOs) and the shifting inclination toward biosimilars over format monoclonal antibodies are acting as other growth-inducing factors. Furthermore, the fueling health concerns have prompted biotechnology companies to engineer effective novel vaccines in collaboration with CRO, especially during the COVID-19 pandemic, which is contributing to the market growth. Moreover, the extensive utilization of in-vivo CRO to perform toxicology and pharmacokinetic studies during preclinical activities is impelling the market growth. Apart from this, the advent of bioequivalence, rapid growth in generics, ongoing patent expirations, and continuous research and development (R&D) activities to engineer personalized medicines are creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Type:

  • Rodent
  • Rats
  • Mice
  • Others
  • Non-Rodent

Breakup by GLP Type:

  • Non-GLP
  • In House
  • Outsourcing
  • GLP Toxicology
  • In House
  • Outsourcing

Breakup by Indication:

Autoimmune/Inflammation Conditions

Rheumatoid Arthritis

Multiple Sclerosis

Osteoarthritis

Irritable Bowel Syndrome

Others

Pain Management

Chronic Pain

Acute Pain

Oncology

Blood Cancer

Solid Tumor

Others

CNS Conditions

Epilepsy

Parkinson's Disease

Huntington's Disease

Stroke

Traumatic Brain Injury

ALS

Muscle Regeneration

Others

Diabetes

Obesity

Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories International Inc., Evotec SE, ICON plc, Iris Pharma (Abionyx Pharma), Labcorp Drug Development (Laboratory Corporation of America Holdings), North American Science Associates LLC, Parexel International Corporation, Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.), Pronexus Analytical AB, Syneos Health and WuXi AppTec.

Key Questions Answered in This Report

  • 1.What was the size of the global in-vivo CRO market in 2024?
  • 2.What is the expected growth rate of the global in-vivo CRO market during 2025-2033?
  • 3.What are the key factors driving the global in-vivo CRO market?
  • 4.What has been the impact of COVID-19 on the global in-vivo CRO market?
  • 5.What is the breakup of the global in-vivo CRO market based on the type?
  • 6.What is the breakup of the global in-vivo CRO market based on the GLP type?
  • 7.What is the breakup of the global in-vivo CRO market based on indication?
  • 8.What are the key regions in the global in-vivo CRO market?
  • 9.Who are the key players/companies in the global in-vivo CRO market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global In-vivo CRO Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Rodent
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Rats
      • 6.1.2.2 Mice
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Non-Rodent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by GLP Type

  • 7.1 Non-GLP
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 In House
      • 7.1.2.2 Outsourcing
    • 7.1.3 Market Forecast
  • 7.2 GLP Toxicology
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 In House
      • 7.2.2.2 Outsourcing
    • 7.2.3 Market Forecast

8 Market Breakup by Indication

  • 8.1 Autoimmune/Inflammation Conditions
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Rheumatoid Arthritis
      • 8.1.2.2 Multiple Sclerosis
      • 8.1.2.3 Osteoarthritis
      • 8.1.2.4 Irritable Bowel Syndrome
      • 8.1.2.5 Others
    • 8.1.3 Market Forecast
  • 8.2 Pain Management
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Chronic Pain
      • 8.2.2.2 Acute Pain
    • 8.2.3 Market Forecast
  • 8.3 Oncology
    • 8.3.1 Market Trends
    • 8.3.2 Key Segments
      • 8.3.2.1 Blood Cancer
      • 8.3.2.2 Solid Tumor
      • 8.3.2.3 Others
    • 8.3.3 Market Forecast
  • 8.4 CNS Conditions
    • 8.4.1 Market Trends
    • 8.4.2 Key Segments
      • 8.4.2.1 Epilepsy
      • 8.4.2.2 Parkinson's Disease
      • 8.4.2.3 Huntington's Disease
      • 8.4.2.4 Stroke
      • 8.4.2.5 Traumatic Brain Injury
      • 8.4.2.6 ALS
      • 8.4.2.7 Muscle Regeneration
      • 8.4.2.8 Others
    • 8.4.3 Market Forecast
  • 8.5 Diabetes
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Obesity
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Charles River Laboratories International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Evotec SE
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 ICON plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Iris Pharma (ABIONYX Pharma)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Labcorp Drug Development (Laboratory Corporation of America Holdings)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 North American Science Associates LLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Parexel International Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Pronexus Analytical AB
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Syneos Health
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 WuXi AppTec
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: In-vivo CRO Market: Major Drivers and Challenges
  • Figure 2: Global: In-vivo CRO Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: In-vivo CRO Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: In-vivo CRO Market: Breakup by Type (in %), 2024
  • Figure 5: Global: In-vivo CRO Market: Breakup by GLP Type (in %), 2024
  • Figure 6: Global: In-vivo CRO Market: Breakup by Indication (in %), 2024
  • Figure 7: Global: In-vivo CRO Market: Breakup by Region (in %), 2024
  • Figure 8: Global: In-vivo CRO (Rodent) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: In-vivo CRO (Rodent) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: In-vivo CRO (Non-Rodent) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: In-vivo CRO (Non-Rodent) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: In-vivo CRO (Non-GLP) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: In-vivo CRO (Non-GLP) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: In-vivo CRO (GLP Toxicology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: In-vivo CRO (GLP Toxicology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: In-vivo CRO (Autoimmune/Inflammation Conditions) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: In-vivo CRO (Autoimmune/Inflammation Conditions) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: In-vivo CRO (Pain Management) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: In-vivo CRO (Pain Management) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: In-vivo CRO (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: In-vivo CRO (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: In-vivo CRO (CNS Conditions) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: In-vivo CRO (CNS Conditions) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: In-vivo CRO (Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: In-vivo CRO (Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: In-vivo CRO (Obesity) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: In-vivo CRO (Obesity) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: In-vivo CRO (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: In-vivo CRO (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: In-vivo CRO Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: In-vivo CRO Industry: SWOT Analysis
  • Figure 80: Global: In-vivo CRO Industry: Value Chain Analysis
  • Figure 81: Global: In-vivo CRO Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: In-vivo CRO Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: In-vivo CRO Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: In-vivo CRO Market Forecast: Breakup by GLP Type (in Million USD), 2025-2033
  • Table 4: Global: In-vivo CRO Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 5: Global: In-vivo CRO Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: In-vivo CRO Market: Competitive Structure
  • Table 7: Global: In-vivo CRO Market: Key Players